These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2371871)

  • 21. [Effect of nicotinamide on atrioventricular conduction in rabbits].
    Jin WZ; Zhou CM; Zhang KJ
    Zhongguo Yao Li Xue Bao; 1984 Sep; 5(3):177-81. PubMed ID: 6239509
    [No Abstract]   [Full Text] [Related]  

  • 22. Basic cardiac electrophysiology and mechanisms of antiarrhythmic agents.
    Perry RS; Illsley SS
    Am J Hosp Pharm; 1986 Apr; 43(4):957-74. PubMed ID: 2871752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Newer antiarrhythmic drugs. An electrophysiologic appreciation.
    Nair KG; Sharma S
    Indian Heart J Teach Ser; 1980; (7):347-58. PubMed ID: 7309056
    [No Abstract]   [Full Text] [Related]  

  • 24. [Electrophysiological effects of vanilol on isolated papillary muscles of guinea pigs and atrioventricular conduction in rabbits].
    Xiao JG; Li XD; Liu TP
    Zhongguo Yao Li Xue Bao; 1987 Jan; 8(1):40-4. PubMed ID: 2955656
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies on the combined use of beta-adrenergic blockade and antiarrhythmic drugs.
    Mazurowa A; Szadowska A; Szmigielski A; Litwinowicz A
    Arch Immunol Ther Exp (Warsz); 1970; 18(2):280-7. PubMed ID: 4393014
    [No Abstract]   [Full Text] [Related]  

  • 26. [The effect of naloxone on rhythm disorders and on the conduction system of the heart].
    Shliakhto EV; Zaĭtsev AA; Panov AV; Ardashev AV; Nifontov EM; Kashina EA; Kazarin VV; Ivanov VV
    Eksp Klin Farmakol; 1996; 59(3):34-6. PubMed ID: 8974581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The anti-arrhythmia activity and effect on the heart conduction system of the new anti-arrhythmia preparation bonnecor].
    Sokolov SF; Golitsyn SP; Malakhov VI; Bankuzov VA; Koltunova MI; Golitsyn LS
    Farmakol Toksikol; 1990; 53(3):57-60. PubMed ID: 2387385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Action potentials of the cellular structures of the atrio-ventricular region of the conducting system of the heart in atrio-ventricular rhythm].
    Kelareva NA; Sineva IV; Udel'nov MG
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1976; 146(2):93-9. PubMed ID: 1084765
    [No Abstract]   [Full Text] [Related]  

  • 29. The cellular action of antiarrhythmic drugs.
    Gold MR; Balke CW
    Heart Dis Stroke; 1993; 2(5):434-8. PubMed ID: 7511029
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of nicotinamide on cardiac A-V conduction and function of sinus node in isolated hearts.
    Zhang KJ; Zhou CM; Zou YL; Zheng HQ; Wang DY
    Chin Med J (Engl); 1984 Oct; 97(10):777-80. PubMed ID: 6242287
    [No Abstract]   [Full Text] [Related]  

  • 31. [Comparative action of ajmaline and chloracetylajmaline on atrio-ventricular conduction in man].
    Guérot C; Valère PE; Castillo-Fenoy A; Coste A; Morice MC
    Coeur Med Interne; 1975; 14(1):129-35. PubMed ID: 1091402
    [No Abstract]   [Full Text] [Related]  

  • 32. New antiarrhythmic drugs.
    Flaker GC; Munuswamy K
    Am Fam Physician; 1982 Nov; 26(5):226-32. PubMed ID: 7148632
    [No Abstract]   [Full Text] [Related]  

  • 33. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of antiarrhythmic drugs in experimental pharmacology.
    Caillard CG; Louis JC
    Methods Find Exp Clin Pharmacol; 1980 Oct; 2(5):223-52. PubMed ID: 6765586
    [No Abstract]   [Full Text] [Related]  

  • 35. Heterogeneous myocardial responsiveness to antiarrhythmic drugs and its role in their therapeutic action.
    Faucon G; Farges JP; Ollagnier M; Lievre M; Durr F
    Arch Farmacol Toxicol; 1977 Dec; 3(3):189-204. PubMed ID: 613978
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of cardiac glycosides on AV nodal impulse formation and conduction.
    Watanabe Y; Noda T; Habuchi Y
    Prog Clin Biol Res; 1988; 275():111-31. PubMed ID: 3174669
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of encainide and its two major metabolites on cardiac conduction.
    Dresel PE
    J Pharmacol Exp Ther; 1984 Jan; 228(1):180-6. PubMed ID: 6420542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of cycleanine dimethobromide on heart conduction system].
    Shen JF; Xi YQ; Cao ZE; Zhang GL; Fu CZ; Gao QL
    Zhongguo Yao Li Xue Bao; 1985 Dec; 6(4):260-3. PubMed ID: 2945367
    [No Abstract]   [Full Text] [Related]  

  • 39. [The influence of antiarrhythmic drugs on parameters of signal-averaged electrocardiography].
    Banasiak W; Bobak J; Telichowski A
    Przegl Lek; 1997; 54(7-8):510-4. PubMed ID: 9480459
    [No Abstract]   [Full Text] [Related]  

  • 40. Electrophysiologic effects of 3-(p-chlorophenyl)-(2-imadazolin-2-yl-methyl)-1,2,3,4-tetrahydro-1-benzepine hydrochloride (SU-13197), a new antiarrhythmic agent.
    Watanabe Y; Dreifus LS
    J Pharmacol Exp Ther; 1968 Jan; 159(1):146-52. PubMed ID: 5643942
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.